Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Articles
Oncology
17 Mar 2015
Development of Drugs Targeting the PI3K Signalling Pathway in Leukaemias and Lymphomas
The phosphoinositide 3-kinase (PI3K) family of signalling enzymes play a key role in the transduction of signals from activated cell surface receptors…
Oncology
17 Mar 2015
Alloimmune Thrombocytopaenic Disorders: A Review
Alloimmune thrombocytopaenia (AIT) is caused by alloantibodies against specific platelet glycoproteins. Alloimmune thrombocytopaenic disorders include…
Oncology
17 Mar 2015
Multiple Myeloma and Renal Failure
Renal failure (RF) occurs in approximately 20-30% of multiple myeloma (MM) patients at diagnosis and in more than 50% of patients with advanced disease.
Oncology
17 Mar 2015
Checkpoint Blockade in Cancer Immunotherapy: Squaring the Circle
Manipulating the complex interaction between the immune system and tumour cells has been the focus of cancer research for many years, but it is only in…
Oncology
17 Mar 2015
How I Treat: Prognostication in Chronic Lymphocytic Leukaemia: A Gaze into the Future
Chronic lymphocytic leukaemia (CLL) is due to the relentless accumulation of monoclonal B lymphocytes with a distinct immunophenotype…
Gastroenterology
3
Mins
10 Mar 2015
Below the Belt, Experiences with Prostate Cancer
There is a new guy on the block. A new guy in the guise of a book written by new-age men talking about their very own personal experiences of their…
Dermatology
4
Mins
3 Mar 2015
When Does Bladder Cancer Get Its Turn?
The past decade, and particularly the past five years have been an exciting time in the management of prostate cancer. After what seemed like an eternity…
Gastroenterology
3
Mins
3 Mar 2015
New Horizons in Prostate Cancer
Research and development in the 21st century is a rapidly changing landscape. Advances in technology have been the driving force to further advances in…
Loading posts...
« Previous
1
…
222
223
224
225
226
…
267
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View